Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients

Biomedicine and Pharmacotherapy

Volumn 83, Issue , 2016, Pages 8-13

  Huang, Congxiu ^a   Yu, Zhilong ^a   Yang, Hao ^a   Lin, Yu ^a  

^a AFFILIATED HOSPITAL OF INNER MONGOLIA MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal cancer; LncRNA; MALAT1; Overall survival; Prognosis

Indexed keywords

LONG UNTRANSLATED RNA; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; UNCLASSIFIED DRUG; MALAT1 LONG NON-CODING RNA, HUMAN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DISTANT METASTASIS; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; GENE EXPRESSION; GROUPS BY AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR LOCALIZATION; UPREGULATION; DISEASE COURSE; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR CELL LINE;

CELL LINE, TUMOR; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; SURVIVAL ANALYSIS; UP-REGULATION;

EID: 84974831609     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.05.044     Document Type: Article

References (27)

1. Chen Y., Tong Y., Yang C., Gan Y., Sun H., Bi H., Cao S., Yin X., Lu Z. Consumption of hot beverages and foods and the risk of esophageal cancer: a meta-analysis of observational studies. BMC Cancer 2015, 15:449.
2. He E., Pan F., Li G., Li J. Fractionated ionizing radiation promotes epithelial-Mesenchymal transition in human esophageal cancer cells through PTEN deficiency-Mediated Akt activation. PLoS One 2015, 10:e0126149.
3. Lordick F., Holscher A.H., Haustermans K., Wittekind C. Multimodal treatment of esophageal cancer. Langenbecks Arch. Surg. 2013, 398:177-187.
4. Chen L., Luo G., Tan Y., Wei J., Wu C., Zheng L., Zhang X., Xu N. Immunolocalisation of tissue factor in esophageal cancer is correlated with intratumoral angiogenesis and prognosis of the patient. Acta Histochem. 2010, 112:233-239.
5. Chen L.J., Sun J., Wu H.Y., Zhou S.M., Tan Y., Tan M., Shan B.E., Lu B.F., Zhang X.G. B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma. Cancer Immunol. Immunother. 2011, 60:1047-1055.
6. Siewert J.R., Ott K. Are squamous and adenocarcinomas of the esophagus the same disease. Semin. Radiat. Oncol. 2007, 17:38-44.
7. Dreikhausen L., Blank S., Sisic L., Heger U., Weichert W., Jager D., Bruckner T., Giese N., Grenacher L., Falk C., Ott K., Schmidt T. Association of angiogenic factors with prognosis in esophageal cancer. BMC Cancer 2015, 15:121.
8. Chen L., Di D., Luo G., Zheng L., Tan Y., Zhang X., Xu N. Immunochemical staining of MT2-MMP correlates positively to angiogenesis of human esophageal cancer. Anticancer Res. 2010, 30:4363-4368.
9. Chen L., Xu Y., Xu B., Deng H., Zheng X., Wu C., Jiang J. Over-expression of lysine-specific demethylase 1 predicts tumor progression and poor prognosis in human esophageal cancer. Int. J. Clin. Exp. Pathol. 2014, 7:8929-8934.
10. Wang G., Chen H., Liu J., Ma Y., Jia H. A comparison of postoperative early enteral nutrition with delayed enteral nutrition in patients with esophageal cancer. Nutrients 2015, 7:4308-4317.
11. Hu L., Wu Y., Tan D., Meng H., Wang K., Bai Y., Yang K. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma. J. Exp. Clin. Cancer Res. 2015, 34:7.
12. Jiang Y., Li Y., Fang S., Jiang B., Qin C., Xie P., Zhou G., Li G. The role of MALAT1 correlates with HPV in cervical cancer. Oncol. Lett. 2014, 7:2135-2141.
13. Thum T., Fiedler J. LINCing MALAT1 and angiogenesis. Circ. Res. 2014, 114:1366-1368.
14. Zheng H.T., Shi D.B., Wang Y.W., Li X.X., Xu Y., Tripathi P., Gu W.L., Cai G.X., Cai S.J. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. Int. J. Clin. Exp. Pathol. 2014, 7:3174-3181.
15. Cho S.F., Chang Y.C., Chang C.S., Lin S.F., Liu Y.C., Hsiao H.H., Chang J.G., Liu T.C. MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression. BMC Cancer 2014, 14:809.
16. Brown J.A., Bulkley D., Wang J., Valenstein M.L., Yario T.A., Steitz T.A., Steitz J.A. Structural insights into the stabilization of MALAT1 noncoding RNA by a bipartite triple helix. Nat. Struct. Mol. Biol. 2014, 21:633-640.
17. Liu J.H., Chen G., Dang Y.W., Li C.J., Luo D.Z. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues. Asian Pac. J. Cancer Prev. 2014, 15:2971-2977.
18. Schorderet P., Duboule D. Structural and functional differences in the long non-coding RNA hotair in mouse and human. PLoS Genet. 2011, 7:e1002071.
19. Wu X.S., Wang X.A., Wu W.G., Hu Y.P., Li M.L., Ding Q., Weng H., Shu Y.J., Liu T.Y., Jiang L., Cao Y., Bao R.F., Mu J.S., Tan Z.J., Tao F., Liu Y.B. MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway. Cancer Biol. Ther. 2014, 15:806-814.
20. Tee A.E., Ling D., Nelson C., Atmadibrata B., Dinger M.E., Xu N., Mizukami T., Liu P.Y., Liu B., Cheung B., Pasquier E., Haber M., Norris M.D., Suzuki T., Marshall G.M., Liu T. The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1. Oncotarget 2014, 5:1793-1804.
21. Chen L., Deng H., Lu M., Xu B., Wang Q., Jiang J., Wu C. B7-H1 expression associates with tumor invasion and predicts patient's survival in human esophageal cancer. Int. J. Clin. Exp. Pathol. 2014, 7:6015-6023.
22. Wang F., Xuan X.Y., Yang X., Cao L., Pang L.N., Zhou R., Fan Q.X., Wang L.X. Stathmin is a marker of progression and poor prognosis in esophageal carcinoma. Asian Pac. J. Cancer Prev. 2014, 15:3613-3618.
23. Fan Y., Shen B., Tan M., Mu X., Qin Y., Zhang F., Liu Y. TGF-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin. Cancer Res. 2014, 20:1531-1541.
24. Xie L., Hu Z., Wang X., Li Z. [Expression of long noncoding RNA MALAT1 gene in human nasopharyngeal carcinoma cell lines and its biological significance]. Nan Fang Yi Ke Da Xue Bao 2013, 33:692-697.
25. Zhang B., Arun G., Mao Y.S., Lazar Z., Hung G., Bhattacharjee G., Xiao X., Booth C.J., Wu J., Zhang C., Spector D.L. The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep. 2012, 2:111-123.
26. Zimmermann T., Moehler M., Gockel I., Sgourakis G.G., Biesterfeld S., Muller M., Berger M.R., Lang H., Galle P.R., Schimanski C.C. Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8+ T-cell infiltration. Int. J. Colorectal Dis. 2010, 25:417-424.
27. Pang E.J., Yang R., Fu X.B., Liu Y.F. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Tumour Biol. 2015, 36:2403-2407.